Literature DB >> 7990149

Expression, crystallization and preliminary crystallographic analysis of human carbonyl reductase.

K M Bohren1, B Wermuth, D Harrison, D Ringe, G A Petsko, K H Gabbay.   

Abstract

The cDNA of human placental carbonyl reductase (EC 1.1.1.184), a member of the short-chain dehydrogenase family of enzymes, was introduced into the plasmid vector pET-11a and the enzyme overexpressed in Escherichia coli. Recombinant carbonyl reductase was purified to homogeneity, characterized physically and kinetically, and crystallized for X-ray diffraction study. The recombinant protein was indistinguishable from human tissue carbonyl reductase (CR8.5 form) on the basis of partial sequence analysis, substrate specificity, susceptibility to inhibitors and immunochemical analysis. Similar to the tissue enzyme which which occurs in multiple molecular forms thought to arise from autocatalytic modification by 2-oxocarboxylic acids, a second form of the recombinant enzyme was generated under bacterial growth conditions producing high pyruvate concentrations. Purified recombinant protein, which corresponds to the smallest, most basic tissue form (CR8.5), was crystallized against 20% polyethyleneglycol 6000 in 25 mM 2-(N-morpholino)ethanesulfonic acid buffer (Mes) at pH 6.0 using the hanging drop method. Crystals of human carbonyl reductase diffract to better than 3.0 A, and the diffraction symmetry is consistent with a crystal that belongs to the tetragonal space group P4(1)(3)2(1)2 with unit cell dimensions of a = b = 55 A, c = 175 A, alpha = beta = gamma = 90.0. The asymmetric unit contains one molecule of 30.2 kDa.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7990149     DOI: 10.1006/jmbi.1994.1762

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  3 in total

1.  Mutation of threonine-241 to proline eliminates autocatalytic modification of human carbonyl reductase.

Authors:  M A Sciotti; S Nakajin; B Wermuth; M E Baker
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

2.  Synthesis of 3-[(N-carboalkoxy)ethylamino]-indazole-dione derivatives and their biological activities on human liver carbonyl reductase.

Authors:  Solomon Berhe; Andrew Slupe; Choice Luster; Henry A Charlier; Don L Warner; Leon H Zalkow; Edward M Burgess; Nkechi M Enwerem; Oladapo Bakare
Journal:  Bioorg Med Chem       Date:  2009-11-10       Impact factor: 3.641

3.  An unbiased cell morphology-based screen for new, biologically active small molecules.

Authors:  Masahiro Tanaka; Raynard Bateman; Daniel Rauh; Eugeni Vaisberg; Shyam Ramachandani; Chao Zhang; Kirk C Hansen; Alma L Burlingame; Jay K Trautman; Kevan M Shokat; Cynthia L Adams
Journal:  PLoS Biol       Date:  2005-04-05       Impact factor: 8.029

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.